Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Beyond Air
XAIR
Beyond Air
Slow Hospital Onboarding Will Constrain Revenue With Eventual Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
18 Aug 25
Updated
18 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$5.00
52.0% undervalued
intrinsic discount
18 Aug
US$2.40
Loading
1Y
-76.7%
7D
-24.1%
Author's Valuation
US$5.0
52.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$5.0
52.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-101m
96m
2014
2017
2020
2023
2025
2026
2028
Revenue US$96.1m
Earnings US$11.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
39.08%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.66%
Calculation
US$11.94m
Earnings '28
x
6.34x
PE Ratio '28
=
US$75.70m
Market Cap '28
US$75.70m
Market Cap '28
/
11.48m
No. shares '28
=
US$6.59
Share Price '28
US$6.59
Share Price '28
Discounted to 2025 @ 9.66% p.a.
=
US$5.00
Fair Value '25
